These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26650031)

  • 21. Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro.
    Zhang H; Li M; Zheng X; Sun Y; Wen Z; Zhao X
    Mol Hum Reprod; 2009 Oct; 15(10):653-63. PubMed ID: 19684091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dienogest in the treatment of endometriosis.
    Bizzarri N; Remorgida V; Leone Roberti Maggiore U; Scala C; Tafi E; Ghirardi V; Salvatore S; Candiani M; Venturini PL; Ferrero S
    Expert Opin Pharmacother; 2014 Sep; 15(13):1889-902. PubMed ID: 25069386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
    Yamanaka A; Kimura F; Kishi Y; Takahashi K; Suginami H; Shimizu Y; Murakami T
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():170-4. PubMed ID: 24953822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells.
    Fu L; Osuga Y; Morimoto C; Hirata T; Hirota Y; Yano T; Taketani Y
    Fertil Steril; 2008 May; 89(5 Suppl):1344-7. PubMed ID: 17511992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
    Ono YJ; Terai Y; Tanabe A; Hayashi A; Hayashi M; Yamashita Y; Kyo S; Ohmichi M
    J Endocrinol; 2014 Nov; 223(2):203-16. PubMed ID: 25244916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons.
    Kyama CM; Overbergh L; Mihalyi A; Cuneo S; Chai D; Debrock S; Mwenda JM; Mathieu C; Nugent NP; D'Hooghe TM
    Fertil Steril; 2008 May; 89(5 Suppl):1306-13. PubMed ID: 18061171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study.
    Nirgianakis K; Vaineau C; Agliati L; McKinnon B; Gasparri ML; Mueller MD
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):30-40. PubMed ID: 32767677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis.
    Yoshino O; Osuga Y; Hirota Y; Koga K; Hirata T; Harada M; Morimoto C; Yano T; Nishii O; Tsutsumi O; Taketani Y
    Am J Reprod Immunol; 2004 Nov; 52(5):306-11. PubMed ID: 15550066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
    Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
    Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
    Beranič N; Lanišnik Rižner T
    Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
    Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Mizuuchi M; Moriwaka O; Kamiya H
    Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
    Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
    Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response.
    Novembri R; Carrarelli P; Toti P; Rocha AL; Borges LE; Reis FM; Piomboni P; Florio P; Petraglia F
    Mol Hum Reprod; 2011 Sep; 17(9):587-93. PubMed ID: 21454316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
    Okada H; Nakajima T; Yoshimura T; Yasuda K; Kanzaki H
    Mol Hum Reprod; 2001 Apr; 7(4):341-7. PubMed ID: 11279296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study.
    Kim HJ; Kim SH; Oh YS; Lee SR; Chae HD
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
    Koshiba A; Mori T; Okimura H; Akiyama K; Kataoka H; Takaoka O; Ito F; Matsushima H; Kusuki I; Kitawaki J
    J Obstet Gynaecol Res; 2018 Oct; 44(10):1970-1976. PubMed ID: 29992672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dienogest attenuates STAT3 activation in ovarian endometriotic cysts.
    Choi J; Jo M; Lee E; Kim SE; Lee DY; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():217-221. PubMed ID: 38301500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells.
    Makabe T; Koga K; Miyashita M; Takeuchi A; Sue F; Taguchi A; Urata Y; Izumi G; Takamura M; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Fujii T; Osuga Y
    J Reprod Immunol; 2017 Feb; 119():44-48. PubMed ID: 28064076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.